Immunitybio Non Recurring from 2010 to 2026
| IBRX Stock | USD 2.59 0.26 11.16% |
Non Recurring | First Reported 2010-12-31 | Previous Quarter 612.9 K | Current Value 544.8 K | Quarterly Volatility 36 K |
Check Immunitybio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immunitybio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 10.1 M, Interest Expense of 159 M or Total Revenue of 17.8 M, as well as many indicators such as Price To Sales Ratio of 132, Dividend Yield of 0.0 or Days Sales Outstanding of 71.75. Immunitybio financial statements analysis is a perfect complement when working with Immunitybio Valuation or Volatility modules.
Immunitybio | Non Recurring | Build AI portfolio with Immunitybio Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Immunitybio Stock Analysis
When running Immunitybio's price analysis, check to measure Immunitybio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunitybio is operating at the current time. Most of Immunitybio's value examination focuses on studying past and present price action to predict the probability of Immunitybio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunitybio's price. Additionally, you may evaluate how the addition of Immunitybio to your portfolios can decrease your overall portfolio volatility.